• 1
    Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36) I. Conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 2
    Ware J Jr, Kosinski M, Keller SD. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 22033.
  • 3
    Ware JE. SF-36 Health Survey update. In: Maruish ME, editor. The use of psychological testing for treatment planning and outcomes assessment. Mahwah (NJ): Lawrence Earlbaum; 2004. p. 693718.
  • 4
    Ware JE, Kosinski MA, Gandek B. SF-36 Health Survey: manual and interpretation guide. Lincoln (RI): Quality Metric; 2005.
  • 5
    Ware JE Jr, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 116770.
  • 6
    Hawthorne G, Osborne RH, Taylor A, Sansoni J. The SF-36 version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res 2007; 16: 66173.
  • 7
    Boardman DL, Dorey F, Thomas BJ, Lieberman JR. The accuracy of assessing total hip arthroplasty outcomes: a prospective correlation study of walking ability and 2 validated measurement devices. J Arthroplasty 2000; 15: 2004.
  • 8
    Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, et al. Reduction of fatigue in Sjögren's syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis 2008; 67: 15414.
  • 9
    Gladman DD, Urowitz MB, Gough J, MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 1997; 24: 21458.
  • 10
    Harrison MJ, Tricker KJ, Davies L, Hassell A, Dawes P, Scott DL, et al. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rheumatol 2005; 32: 23306.
  • 11
    Soderlin MK, Lindroth Y, Turesson C, Jacobsson LT. A more active treatment has profound effects on the health status of rheumatoid arthritis (RA) patients: results from a population-based RA register in Malmo, Sweden, 1997-2005. Scand J Rheumatol 2010; 39: 20611.
  • 12
    Heiberg MS, Nordvag BY, Mikkelsen K, Rodevand E, Kaufmann C, Mowinckel P, et al. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study. Arthritis Rheum 2005; 52: 250612.
  • 13
    Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol 2009; 36: 10418.
  • 14
    Busija L, Osborne RH, Nilsdotter A, Buchbinder R, Roos EM. Magnitude and meaningfulness of change in SF-36 scores in four types of orthopedic surgery. Health Qual Life Outcomes 2008; 6: 55.
  • 15
    Dervin GF, Stiell IG, Rody K, Grabowski J. Effect of arthroscopic debridement for osteoarthritis of the knee on health-related quality of life. J Bone Joint Surg Am 2003; 85A: 109.
  • 16
    Dierick F, Aveniere T, Cossement M, Poilvache P, Lobet S, Detrembleur C. Outcome assessment in osteoarthritic patients undergoing total knee arthroplasty. Acta Orthop Belg 2004; 70: 3845.
  • 17
    Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, et al, Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 2004; 50: 105165.
  • 18
    Linde K, Weidenhammer W, Streng A, Hoppe A, Melchart D. Acupuncture for osteoarthritic pain: an observational study in routine care. Rheumatology (Oxford) 2006; 45: 2227.
  • 19
    Ferrara PE, Rabini A, Maggi L, Piazzini DB, Logroscino G, Magliocchetti G, et al. Effect of pre-operative physiotherapy in patients with end-stage osteoarthritis undergoing hip arthroplasty. Clin Rehabil 2008; 22: 97786.
  • 20
    Sutbeyaz ST, Sezer N, Koseoglu F, Kibar S. Low-frequency pulsed electromagnetic field therapy in fibromyalgia: a randomized, double-blind, sham-controlled clinical study. Clin J Pain 2009; 25: 7228.
  • 21
    Wang C, Schmid CH, Hibberd PL, Kalish R, Roubenoff R, Rones R, et al. Tai Chi is effective in treating knee osteoarthritis: a randomized controlled trial. Arthritis Rheum 2009; 61: 154553.
  • 22
    Coleman S, Briffa NK, Carroll G, Inderjeeth C, Cook N, McQuade J. Effects of self-management, education and specific exercises, delivered by health professionals, in patients with osteoarthritis of the knee. BMC Musculoskelet Disord 2008; 9: 133.
  • 23
    Carmona L, Ballina J, Gabriel R, Laffon A. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 2001; 60: 10405.
  • 24
    Hill CL, Gill T, Taylor AW, Daly A, Grande ED, Adams RJ. Psychological factors and quality of life in arthritis: a population-based study. Clin Rheumatol 2007; 26: 104954.
  • 25
    Gandhi SK, Salmon JW, Zhao SZ, Lambert BL, Gore PR, Conrad K. Psychometric evaluation of the 12-item Short-Form Health Survey (SF-12) in osteoarthritis and rheumatoid arthritis clinical trials. Clin Ther 2001; 23: 108098.
  • 26
    Theiler R, Bischoff HA, Good M, Uebelhart D. Rofecoxib improves quality of life in patients with hip or knee osteoarthritis. Swiss Med Wkly 2002; 132: 56673.
  • 27
    Foley A, Halbert J, Hewitt T, Crotty M. Does hydrotherapy improve strength and physical function in patients with osteoarthritis: a randomised controlled trial comparing a gym based and a hydrotherapy based strengthening programme. Ann Rheum Dis 2003; 62: 11627.
  • 28
    Calandre EP, Rodriguez-Claro ML, Rico-Villademoros F, Vilchez JS, Hidalgo J, Delgado-Rodriguez A. Effects of pool-based exercise in fibromyalgia symptomatology and sleep quality: a prospective randomised comparison between stretching and Ai Chi. Clin Exp Rheumatol 2009; 27: S218.
  • 29
    Fransen M, Nairn L, Winstanley J, Lam P, Edmonds J. Physical activity for osteoarthritis management: a randomized controlled clinical trial evaluating hydrotherapy or Tai Chi classes. Arthritis Rheum 2007; 57: 40714.
  • 30
    McCalden RW, MacDonald SJ, Rorabeck CH, Bourne RB, Chess DG, Charron KD. Wear rate of highly cross-linked polyethylene in total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 2009; 91: 77382.
  • 31
    Thomas S, Kinninmonth AW, Kumar CS. Long-term results of the modified Hoffman procedure in the rheumatoid forefoot: surgical technique. J Bone Joint Surg Am 2006; 88 Suppl 1: 14957.
  • 32
    Schick M, Stucki G, Rodriguez M, Meili EO, Huber E, Michel BA, et al. Haemophilic arthropathy: assessment of quality of life after total knee arthroplasty. Clin Rheumatol 1999; 18: 46872.
  • 33
    Stockl KM, Shin JS, Lew HC, Zakharyan A, Harada AS, Solow BK, et al. Outcomes of a rheumatoid arthritis disease therapy management program focusing on medication adherence. J Manag Care Pharm 2010; 16: 593604.
  • 34
    Bowling A, Bond M, Jenkinson C, Lamping DL. Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, the Health Survey for England and the Oxford Healthy Life Survey. J Public Health Med 1999; 21: 25570.
  • 35
    McHorney CA, Kosinski M, Ware JE Jr. Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey. Med Care 1994; 32: 55167.
  • 36
    Lyons RA, Wareham K, Lucas M, Price D, Williams J, Hutchings HA. SF-36 scores vary by method of administration: implications for study design. J Public Health Med 1999; 21: 415.
  • 37
    Weinberger M, Oddone EZ, Samsa GP, Landsman PB. Are health-related quality-of-life measures affected by the mode of administration? J Clin Epidemiol 1996; 49: 13540.
  • 38
    Jones D, Kazis L, Lee A, Rogers W, Skinner K, Cassar L, et al. Health status assessments using the Veterans SF-12 and SF-36: methods for evaluating otucomes in the Veterans Health Administration. J Ambul Care Manage 2001; 24: 6886.
  • 39
    Perkins JJ, Sanson-Fisher RW. An examination of self- and telephone-administered modes of administration for the Australian SF-36. J Clin Epidemiol 1998; 51: 96973.
  • 40
    Millard RW, Carver JR. Cross-sectional comparison of live and interactive voice recognition administration of the SF-12 health status survey. Am J Manag Care 1999; 5: 1539.
  • 41
    Ball AE, Russell EM, Seymour DG, Primrose WR, Garratt AM. Problems in using health survey questionnaires in older patients with physical disabilities: can proxies be used to complete the SF-36? Gerontology 2001; 47: 33440.
  • 42
    Yip JY, Wilber KH, Myrtle RC, Grazman DN. Comparison of older adult subject and proxy responses on the SF-36 health-related quality of life instrument. Aging Ment Health 2001; 5: 13642.
  • 43
    Kosinski M, Bayliss M, Bjorner JB, Ware JE. Improving estimates of SF-36-1 Health Survey scores for respondents with missing data. Med Outcome Trust Mon 2000; 5: 810.
  • 44
    Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33: AS26479.
  • 45
    Jenkinson C, Coulter A, Wright L. Short form 36 (SF-36) health survey questionnaire: normative data for adults of working age. BMJ 1993; 306: 143740.
  • 46
    Watson EK, Firman DW, Baade PD, Ring I. Telephone administration of the SF-36 health survey: validation studies and population norms for adults in Queensland. Aust N Z J Public Health 1996; 20: 35963.
  • 47
    Australian Bureau of Statistics. National health survey: SF36 population norms, Australia, 1995. Cat. no. 4399.0. Canberra (Australia): ABS; 1997.
  • 48
    Sullivan M, Karlsson J, Ware JE. SF-36 Swedish manual and interpretation guide. Gothenburg: Gothenburg University; 1994.
  • 49
    Thumboo J, Chan SP, Machin D, Soh CH, Feng PH, Boey ML, et al. Measuring health-related quality of life in Singapore: normal values for the English and Chinese SF-36 health survey. Ann Acad Med Singapore 2002; 31: 36674.
  • 50
    Scott KM, Tobias MI, Sarfati D, Haslett SJ. SF-36 health survey reliability, validity and norms for New Zealand. Aust N Z J Public Health 1999; 23: 4016.
  • 51
    Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making 2006; 26: 391400.
  • 52
    Ware JE, Kosinski MA, Turner-Bowker DM, Gandek B. SF-12: how to score version 2 of the SF-12 Health Survey (with a supplement documenting version 1). Lincoln (RI): QualityMetric; 2002.
  • 53
    Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 11718.
  • 54
    Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000; 17: 1335.
  • 55
    Parker SG, Bechinger-English D, Jagger C, Spiers N, Lindesay J. Factors affecting completion of the SF-36 in older people. Age Ageing 2006; 35: 37681.
  • 56
    Adamson J, Gooberman-Hill R, Woolhead G, Donovan J. ‘Questerviews’: using questionnaires in qualitative interviews as a method of integrating qualitative and quantitative health services research. J Health Sci Res Pol 2004; 9: 13945.
  • 57
    Fowler RW, Congdon P, Hamilton S. Assessing health status and outcomes in a geriatric day hospital. Public Health 2000; 114: 4405.
  • 58
    DeBrota DJ, Bradt EW, Andrejasich CM, Kosinski M, Ware JE. Comparison of interactive voice response SF-36 to self-administered SF-36 and personal interview via telephone SF-36: Boston: The Health Institute, New England Medical Center; 1996.
  • 59
    Sanson-Fisher RW, Perkins JJ. Adaptation and validation of the SF-36 Health Survey for use in Australia. J Clin Epidemiol 1998; 51: 9617.
  • 60
    Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study: an application of methods for monitoring the results of medical care. JAMA 1989; 262: 92530.
  • 61
    Koh ET, Leong KP, Tsou IY, Lim VH, Pong LY, Chong SY, et al. The reliability, validity and sensitivity to change of the Chinese version of SF-36 in oriental patients with rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 10238.
  • 62
    Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol 1998; 51: 106976.
  • 63
    Parker SG, Peet SM, Jagger C, Farhan M, Castleden CM. Measuring health status in older patients: the SF-36 in practice. Age Ageing 1998; 27: 138.
  • 64
    Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Rasmussen C, Jensen DV, et al. What factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire? J Rheumatol 2009; 36: 21839.
  • 65
    Soderman P, Malchau H. Validity and reliability of Swedish WOMAC osteoarthritis index: a self-administered disease-specific questionnaire (WOMAC) versus generic instruments (SF-36 and NHP). Acta Orthop Scand 2000; 71: 3946.
  • 66
    Saleh KJ, Radosevich DM, Kassim RA, Moussa M, Dykes D, Bottolfson H, et al. Comparison of commonly used orthopaedic outcome measures using palm-top computers and paper surveys. J Orthop Res 2002; 20: 114651.
  • 67
    Kvien TK, Kaasa S, Smedstad LM. Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 1998; 51: 107786.
  • 68
    Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D (corrected) RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008; 35: 152837.
  • 69
    Kosinski M, Keller SD, Hatoum HT, Kong SX, Ware JE Jr. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability. Med Care 1999; 37: MS1022.
  • 70
    Ruta DA, Hurst NP, Kind P, Hunter M, Stubbings A. Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol 1998; 37: 42536.
  • 71
    Davey RC, Edwards SM, Cochrane T. Test-retest reliability of lower extremity functional and self-reported measures in elderly with osteoarthritis. Adv Physiother 2003; 5: 15561.
  • 72
    Brazier JE, Harper R, Munro J, Walters SJ, Snaith ML. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford) 1999; 38: 8707.
  • 73
    Jakobsson U, Westergren A, Lindskov S, Hagell P. Construct validity of the SF-12 in three different samples. J Eval Clin Pract. E-pub ahead of print.
  • 74
    Lenert LA. The reliability and internal consistency of an Internet-capable computer program for measuring utilities. Qual Life Res 2000; 9: 8117.
  • 75
    Lim LL, Fisher JD. Use of the 12-item Short-Form (SF-12) Health Survey in an Australian heart and stroke population. Qual Life Res 1999; 8: 18.
  • 76
    Luo X, Lynn George M, Kakouras I, Edwards CL, Pietrobon R, Richardson W, et al. Reliability, validity, and responsiveness of the short form 12-item survey (SF-12) in patients with back pain. Spine (Phila Pa 1976) 2003; 28: 173945.
  • 77
    Resnick B, Nahm ES. Reliability and validity testing of the revised 12-item Short-Form Health Survey in older adults. J Nurs Meas 2001; 9: 15161.
  • 78
    Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC. Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care 2000; 38: 114150.
  • 79
    Keller SD, Ware JE Jr, Bentler PM, Aaronson NK, Alonso J, Apolone G, et al. Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 117988.
  • 80
    Wolinsky FD, Stump TE. A measurement model of the Medical Outcomes Study 36-Item Short-Form Health Survey in a clinical sample of disadvantaged, older, black, and white men and women. Med Care 1996; 34: 53748.
  • 81
    Shields RK, Enloe LJ, Leo KC. Health related quality of life in patients with total hip or knee replacement. Arch Phys Med Rehabil 1999; 80: 5729.
  • 82
    Kontodimopoulos N, Pappa E, Niakas D, Tountas Y. Validity of SF-12 summary scores in a Greek general population. Health Qual Life Outcomes 2007; 5: 55.
  • 83
    Montazeri A, Vahdaninia M, Mousavi SJ, Omidvari S. The Iranian version of 12-item Short Form Health Survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health 2009; 9: 341.
  • 84
    Maurischat C, Ehlebracht-Konig I, Kuhn A, Bullinger M. Factorial validity and norm data comparison of the Short Form 12 in patients with inflammatory-rheumatic disease. Rheumatol Int 2006; 26: 61421.
  • 85
    Fleishman JA, Selim AJ, Kazis LE. Deriving SF-12v2 physical and mental health summary scores: a comparison of different scoring algorithms. Qual Life Res 2010; 19: 23141.
  • 86
    Veehof MM, ten Klooster PM, Taal E, van Riel PL, van de Laar MA. Comparison of internal and external responsiveness of the generic Medical Outcome Study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis. J Rheumatol 2008; 35: 6107.
  • 87
    Fan ZJ, Smith CK, Silverstein BA. Assessing validity of the QuickDASH and SF-12 as surveillance tools among workers with neck or upper extremity musculoskeletal disorders. J Hand Ther 2008; 21: 35465.
  • 88
    Hunt SM, McKenna SP, McEwen J, Backett EM, Williams J, Papp E. A quantitative approach to perceived health status: a validation study. J Epidemiol Comm Health 1980; 34: 2816.
  • 89
    Jenkinson C, Fitzpatrick R, Argyle M. The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. Soc Sci Med 1988; 27: 14114.
  • 90
    Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med A 1981; 15: 2219.
  • 91
    Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985; 35: 1858.
  • 92
    Baillet A, Payraud E, Niderprim VA, Nissen MJ, Allenet B, François P, et al. A dynamic exercise programme to improve patients' disability in rheumatoid arthritis: a prospective randomized controlled trial. Rheumatology (Oxford) 2009; 48: 4105.
  • 93
    Ekici G, Bakar Y, Akbayrak T, Yuksel I. Comparison of manual lymph drainage therapy and connective tissue massage in women with fibromyalgia: a randomized controlled trial. J Manipulative Physiol Ther 2009; 32: 12733.
  • 94
    Yurtkuran M, Alp A, Nasircilar A, Bingol U, Altan L, Sarpdere G. Balneotherapy and tap water therapy in the treatment of knee osteoarthritis. Rheumatol Int 2006; 27: 1927.
  • 95
    Evcik D, Kavuncu V, Yeter A, Yigit I. The efficacy of balneotherapy and mud-pack therapy in patients with knee osteoarthritis. Joint Bone Spine 2007; 74: 605.
  • 96
    Knahr K, Korn V, Kryspin-Exner I, Jagsch R. Quality of life five years after total or partial knee arthroplasty. Z Orthop Ihre Grenzgeb 2003; 141: 2732. In German.
  • 97
    Atroshi I, Ornstein E, Franzen H, Johnsson R, Stefansdottir A, Sundberg M. Quality of life after hip revision with impaction bone grafting on a par with that 4 years after primary cemented arthroplasty. Acta Orthop Scand 2004; 75: 67783.
  • 98
    Uutela T, Hannonen P, Kautiainen H, Hakala M, Paananen ML, Hakkinen A. Positive treatment response improves the health-related quality of life of patients with early rheumatoid arthritis. Clin Exp Rheumatol 2009; 27: 10811.
  • 99
    Wigers SH, Finset A. Rehabilitation of chronic myofascial pain disorders. Tidsskr Nor Laegeforen 2007; 127: 6048. In Norwegian.
  • 100
    Kersten P, Mullee MA, Smith JA, McLellan L, George S. Generic health status measures are unsuitable for measuring health status in severely disabled people. Clin Rehabil 1999; 13: 21928.
  • 101
    Vidalis A, Syngelakis M, Papathanasiou M, Whalley D, McKenna SP. The Greek version of the Nottingham Health Profile: features of its adaptation. Hippokratia 2002; 6 Suppl 1: 758.
  • 102
    Bucquet D, Condon S, Ritchie K. The French version of the Nottingham Health Profile: a comparison of items weights with those of the source version. Soc Sci Med 1990; 30: 82935.
  • 103
    Wiklund I, Romanus B, Hunt SM. Self-assessed disability in patients with arthrosis of the hip joint: reliability of the Swedish version of the Nottingham Health Profile. Disabil Rehabil 1988; 10: 15963.
  • 104
    Essink-Bot ML, Krabbe PF, Bonsel GJ, Aaronson NK. An empirical comparison of four generic health status measures: the Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument. Med Care 1997; 35: 52237.
  • 105
    Alonso J, Prieto L, Anto JM. The Spanish version of the Nottingham Health Profile: a review of adaptation and instrument characteristics. Qual Life Res 1994; 3: 38593.
  • 106
    Hunt SM, McEwen J, McKenna SP. Measuring health status. London: Croom Helm; 1986.
  • 107
    Post MW, Gerritsen J, Diederiks JP, De Witte LP. Measuring health status of people who are wheelchair-dependent: validity of the sickness impact profile 68 and the Nottingham health profile. Disabil Rehabil 2001; 23: 24553.
  • 108
    Nagyova I, van den Heuvel W, Steward R, Macejova Z, van Dijk J. Predictors of change in self-rated health: a longitudinal analysis in patients with rheumatoid arthritis. Netherlands: University of Groningen; 2005.
  • 109
    VanderZee KI, Sanderman R, Heyink J. A comparison of two multidimensional measures of health status: the Nottingham Health Profile and the RAND 36-Item Health Survey 1.0. Qual Life Res 1996; 5: 16574.
  • 110
    Hunt SM, McKenna SP, Williams J. Reliability of a population survey tool for measuring perceived health problems: a study of patients with osteoarthrosis. J Epidemiol Comm Health 1981; 35: 297300.
  • 111
    Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 1997; 50: 7993.
  • 112
    Bouchet C, Guillemin F, Briancon S. Comparison of 3 quality of life instruments in the longitudinal study of rheumatoid arthritis. Rev Epidemiol Sante Publique 1995; 43: 2508. In French.
  • 113
    Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A, Mowat A. A generic health status instrument in the assessment of rheumatoid arthritis. Br J Rheumatol 1992; 31: 8790.
  • 114
    Houssien DA, McKenna SP, Scott DL. The Nottingham Health Profile as a measure of disease activity and outcome in rheumatoid arthritis. Br J Rheumatol 1997; 36: 6973.
  • 115
    Fitzpatrick R, Ziebland S, Jenkinson C, Mowat A. Importance of sensitivity to change as a criterion for selecting health status measures. Qual Health Care 1992; 1: 8993.
  • 116
    Bachrach-Lindstrom M, Karlsson S, Pettersson LG, Johansson T. Patients on the waiting list for total hip replacement: a 1-year follow-up study. Scand J Caring Sci 2008; 22: 53642.
  • 117
    Lillegraven S, Kvien TK. Measuring disability and quality of life in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007; 21: 82740.
  • 118
    De Bruin AF, Buys M, De Witte LP, Diederiks JP. The sickness impact profile: SIP68, a short generic version. First evaluation of the reliability and reproducibility. J Clin Epidemiol 1994; 47: 86371.
  • 119
    Gilson BS, Gilson JS, Bergner M, Bobbit RA, Kressel S, Pollard WE, et al. The sickness impact profile: development of an outcome measure of health care. Am J Public Health 1975; 65: 130410.
  • 120
    Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981; 19: 787805.
  • 121
    De Bruin AF, Diederiks JP, De Witte LP, Stevens FC, Philipsen H. The development of a short generic version of the sickness impact profile. J Clin Epidemiol 1994; 47: 40718.
  • 122
    Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine 1983; 8: 1414.
  • 123
    Sullivan M, Ahlmen M, Bjelle A, Karlsson J. Health status assessment in rheumatoid arthritis. II. Evaluation of a modified Shorter Sickness Impact Profile. J Rheumatol 1993; 20: 15007.
  • 124
    Knutsson S, Engberg IB. An evaluation of patients' quality of life before, 6 weeks and 6 months after total hip replacement surgery. J Adv Nurs 1999; 30: 134959.
  • 125
    Tak E, Staats P, Van Hespen A, Hopman-Rock M. The effects of an exercise program for older adults with osteoarthritis of the hip. J Rheumatol 2005; 32: 110613.
  • 126
    Ahlmen M, Sullivan M, Bjelle A. Team versus non-team outpatient care in rheumatoid arthritis: a comprehensive outcome evaluation including an overall health measure. Arthritis Rheum 1988; 31: 4719.
  • 127
    SIP (Sickness Impact Profile). Mapi Research Trust Education Information Dissemination, 2010. URL:
  • 128
    Agel J, Swiontkowski MF. Guide to outcomes instruments for musculoskeletal trauma research. J Orthop Trauma 2006; 20: S1146.
  • 129
    De Bruin AF, De Witte LP, Stevens F, Diederiks JP. Sickness impact profile: the state of the art of a generic functional status measure. Soc Sci Med 1992; 35: 100314.
  • 130
    Gilson BS, Bergner M, Bobbitt RA, Carter WB. The Sickness Impact Profile: final development and testing. Hyattsville (MD): National Center for Health Services Research; 1979.
  • 131
    Rothman ML, Hedrick S, Inui T. The Sickness Impact Profile as a measure of the health status of noncognitively impaired nursing home residents. Med Care 1989; 27: S15767.
  • 132
    Anonymous. The Sickness Impact Profile 68 (SIP 68). Spinal Cord Injury Rehabilitation Evidence 2010. URL:
  • 133
    Sickness Impact Profile (SIP). 2010. URL:
  • 134
    Patrick D, Peach H, editors. Disablement in the community. Oxford: Oxford University Press; 1989.
  • 135
    Bergner M, Bobbitt RA, Kressel S. The Sickness Impact Profile: conceptual formulation and methodology for the development of a health status measure. Int J Health Serv 1976; 6: 393415.
  • 136
    Andresen EM, Rothenberg BM, Kaplan RM. Performance of a self-administered mailed version of the quality of well-being (QWB-SA) questionnaire among older adults. Med Care 1998; 36: 134960.
  • 137
    Van Straten A, De Haan RJ, Limburg M, Schuling J, Bossuyt PM, van den Bos GA. A stroke-adapted 30-item version of the sickness impact profile to assess quality of life (SA-SIP30). Stroke 1997; 28: 215561.
  • 138
    Nanda U, McLendon PM, Andresen EM, Armbrecht E. The SIP68: an abbreviated sickness impact profile for disability outcomes research. Qual Life Res 2003; 12: 58395.
  • 139
    Kessler S, Jaeckel W, Cziske R. Assessing health in musculoskeletal disorders: the appropriateness of a German version of the Sickness Impact Profile. Rheumatol Int 1997; 17: 11925.
  • 140
    Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991; 12: 142S58S.
  • 141
    Pollard WE, Bobbitt RA, Bergner M, Martin DP, Gilson BS. The Sickness Impact Profile: reliability of a health status measure. Med Care 1976; 14: 14655.
  • 142
    Andresen EM, Nanda U, McLendon P, Meyer A, Armbrech E. SIP68: an abbreviated Sickness Impact Profile for disability outcomes research? [abstract]. Qual Life Res 2000; 9: 343.
  • 143
    Weinberger M, Samsa GP, Tierney WM, Belyea MJ, Hiner SL. Generic versus disease specific health status measures: comparing the Sickness Impact Profile and the Arthritis Impact Measurement Scales. J Rheumatol 1992; 19: 5436.
  • 144
    Deyo RA, Patrick DL. The significance of treatment effects: the clinical perspective. Med Care 1995; 33: AS28691.
  • 145
    Post MW, Gerritsen J, van Leusen ND, Paping MA, Prevo AJ. Adapting the Nottingham Health Profile for use in people with severe physical disabilities. Clin Rehabil 2001; 15: 10310.
  • 146
    Deyo RA, Inui TS. Toward clinical applications of health status measures: sensitivity of scales to clinically important changes. Health Serv Res 1984; 19: 27589.
  • 147
    Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992; 30: 91725.
  • 148
    Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990; 28: 63242.
  • 149
    Bryan S, Longworth L. Measuring health-related utility: why the disparity between EQ-5D and SF-6D? Eur J Health Econ 2005; 6: 25360.
  • 150
    Grieve R, Grishchenko M, Cairns J. SF-6D versus EQ-5D: reasons for differences in utility scores and impact on reported cost-utility. Eur J Health Econ 2009; 10: 1523.
  • 151
    Hawthorne G, Richardson J. Measuring the value of program outcomes: a review of multiattribute utility measures. Expert Rev Pharmacoeconomics Outcome Res 2001; 1: 21528.
  • 152
    Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005; 14: 152332.
  • 153
    Wolfe F, Michaud K, Wallenstein G. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis. J Rheumatol 2010; 37: 161525.
  • 154
    Joore M, Brunenberg D, Nelemans P, Wouters E, Kuijpers P, Honig A, et al. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies. Value Health 2010; 13: 2229.
  • 155
    Konerding U, Moock J, Kohlmann T. The classification systems of the EQ-5D, the HUI II and the SF-6D: what do they have in common? Qual Life Res 2009; 18: 124961.
  • 156
    Marra CA, Marion SA, Guh DP, Najafzadeh M, Wolfe F, Esdaile JM, et al. Not all “quality-adjusted life years” are equal. J Clin Epidemiol 2007; 60: 61624.
  • 157
    Osnes-Ringen H, Kvamme MK, Kristiansen IS, Thingstad M, Henriksen JE, Kvien TK, et al. Cost-effectiveness analyses of elective orthopaedic surgical procedures in patients with inflammatory arthropathies. Scand J Rheumatol 2011; 2: 10815.
  • 158
    Barton GR, Sach TH, Avery AJ, Doherty M, Jenkinson C, Muir KR. Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain [abstract]. Cost Eff Resour Alloc 2009; 7: 12.
  • 159
    Barton GR, Sach TH, Doherty M, Avery AJ, Jenkinson C, Muir KR. An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditions. Eur J Health Econ 2008; 9: 23749.
  • 160
    Sach TH, Barton GR, Jenkinson C, Doherty M, Avery AJ, Muir KR. Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter? Med Care 2009; 47: 88994.
  • 161
    Ruchlin HS, Insinga RP. A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation. Pharmacoeconomics 2008; 26: 92535.
  • 162
    Seymour J, McNamee P, Scott A, Tinelli M. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ 2010; 19: 68396.
  • 163
    Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21: 27192.
  • 164
    Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004; 42: 8519.
  • 165
    Boonen A, Patel V, Traina S, Chiou CF, Maetzel A, Tsuji W. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept. J Rheumatol 2008; 35: 6627.
  • 166
    Zijlstra TR, Braakman-Jansen LM, Taal E, Rasker JJ, van de Laar MA. Cost-effectiveness of spa treatment for fibromyalgia: general health improvement is not for free. Rheumatology (Oxford) 2007; 46: 14549.
  • 167
    Van den Hout WB, de Jong Z, Munneke M, Hazes JM, Breedveld FC, Vliet Vlieland TP. Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis. Arthritis Rheum 2005; 53: 3947.
  • 168
    Uhlig T, Loge JH, Kristiansen IS, Kvien TK. Quantification of reduced health-related quality of life in patients with rheumatoid arthritis compared to the general population. J Rheumatol 2007; 34: 12417.
  • 169
    Fryback DG, Dunham NC, Palta M, Hanmer J, Buechner J, Cherepanov D, et al. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care 2007; 45: 116270.
  • 170
    Furlong W, Feeny D, Torrance GW, Barr R, Horsman J. Guide to design and development of health state utility instrumentation. Hamilton (Ontario): Centre for Health Economics and Policy Analysis, McMaster University; 1990.
  • 171
    Barton GR, Sach TH, Avery AJ, Jenkinson C, Doherty M, Whynes DK, et al. A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years. Health Econ 2008; 17: 81532.
  • 172
    Slobogean GP, Noonan VK, O'Brien PJ. The reliability and validity of the Disabilities of Arm, Shoulder, and Hand, EuroQol-5D, Health Utilities Index, and Short Form-6D outcome instruments in patients with proximal humeral fractures. J Shoulder Elbow Surg 2010; 19: 3428.
  • 173
    Khanna D, Furst DE, Wong WK, Tsevat J, Clements PJ, Park GS, et al. Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis. Qual Life Res 2007; 16: 108392.
  • 174
    Boonen A, van der Heijde D, Landewe R, van Tubergen A, Mielants H, Dougados M, et al. How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis? Ann Rheum Dis 2007; 66: 7717.
  • 175
    Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Farragher TM, Verstappen SM, et al. Why do patients with inflammatory arthritis often score states “worse than death” on the EQ-5D? An investigation of the EQ-5D classification system. Value Health 2009; 12: 102634.
  • 176
    Kontodimopoulos N, Pappa E, Papadopoulos AA, Tountas Y, Niakas D. Comparing SF-6D and EQ-5D utilities across groups differing in health status. Qual Life Res 2009; 18: 8797.
  • 177
    Goncalves Campolina A, Bruscato Bortoluzzo A, Bosi Ferraz M, Mesquita Ciconelli R. Validity of the SF-6D index in Brazilian patients with rheumatoid arthritis. Clin Exp Rheumatol 2009; 27: 23745.
  • 178
    Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, et al. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol 2009; 36: 120916.
  • 179
    Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005; 60: 157182.
  • 180
    Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004; 13: 87384.
  • 181
    Petrou S, Hockley C. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Econ 2005; 14: 116989.
  • 182
    Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Verstappen SM, Watson K, et al. The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis. Qual Life Res 2009; 18: 1195205.
  • 183
    Adams R, Walsh C, Veale D, Bresnihan B, FitzGerald O, Barry M. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis. Pharmacoeconomics 2010; 28: 47787.
  • 184
    Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index(HUI®): concepts, measurement properties and applications. Health Qual Life Outcome 2003; 1: 54.
  • 185
    The Health Utilities Index. 2010. URL:
  • 186
    Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982; 30: 104369.
  • 187
    Boyle M, Furlong W, Torrance G, Feeny D. Reliability of the Health Utilities Index-mark III used in the 1991 cycle 6 general social survey health questionnaire. Ontario: Center for Health Economics and Policy Analysis; 1994.
  • 188
    Strand V, Singh JA. Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity. Drugs 2010; 70: 12145.
  • 189
    Mittendorf T, Dietz B, Sterz R, Kupper H, Cifaldi MA, von der Schulenburg JM. Improvement and longterm maintenance of quality of life during treatment with adalimumab in severe rheumatoid arthritis. J Rheumatol 2007; 34: 234350.
  • 190
    Prince FH, Geerdink LM, Borsboom GJ, Twilt M, van Rossum MA, Hoppenreijs EP, et al. Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis. Ann Rheum Dis 2010; 69: 13842.
  • 191
    Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage 2002; 10: 50617.
  • 192
    Cadman D, Goldsmith C, Torrance G, Boyle M, Furlong W. Development of a health status index for Ontario children. Hamilton (Ontario): McMaster University, Centre for Health Economics and Policy Analysis; 1986. Final Report to Ontario Ministry of Health Research, grant DM648: (00633).
  • 193
    Feeny DH, Torrance GW, Furlong WJ. Health Utilities Index. In: Bert Spilker, editor. Quality of life and pharmacoeconomics in clinical trials: part 2. Vol. 26. Philadelphia: Lippincott-Raven Press; 1996. pp. 23952.
  • 194
    Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, et al. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. J Rheumatol 2003; 30: 226874.
  • 195
    Ruiz MA, Rejas J, Soto J, Pardo A, Rebollo I. Adaptation and validation of the Health Utilities Index Mark 3 into Spanish and correction norms for Spanish population. Qual Life Res 2002; 11: 128.
  • 196
    Pressler SJ, Eckert GJ, Morrison GC, Murray MD, Oldridge NB. Evaluation of the Health Utilities Index Mark-3 in heart failure. J Card Fail 2011; 2: 14350.
  • 197
    Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM, et al. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res 2005; 14: 133344.
  • 198
    Boyle MH, Furlong W, Feeny D, Torrance GW, Hatcher J. Reliability of the Health Utilities Index-mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire. Qual Life Res 1995; 4: 24957.
  • 199
    Blanchard C, Feeny D, Mahon JL, Bourne R, Rorabeck C, Stitt L, et al. Is the Health Utilities Index valid in total hip arthroplasty patients? Qual Life Res 2004; 13: 33948.
  • 200
    Grootendorst P, Feeny D, Furlong W. Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med Care 2000; 38: 2909.
  • 201
    Blanchard C, Feeny D, Mahon JL, Bourne R, Rorabeck C, Stitt L, et al. Is the Health Utilities Index responsive in total hip arthroplasty patients? J Clin Epidemiol 2003; 56: 104654.
  • 202
    Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med 2001; 33: 3449.
  • 203
    Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the index of well-being. Health Serv Res 1976; 11: 478507.
  • 204
    Kaplan RM, Sieber WJ, Ganiats TG. The quality of well-being scale: comparison of the interviewer-administered version with a self-administered questionnaire. Psych Health 1997; 12: 78391.
  • 205
    Seiber WJ, Groessl EJ, David KM, Ganiats TG, Kaplan RM. Quality of Well Being Self-Administered (QWB-SA) Scale: user's manual. San Diego: Health Services Research Center, University of California; 2008.
  • 206
    Groessl EJ, Kaplan RM, Cronan TA. Quality of well-being in older people with osteoarthritis. Arthritis Rheum 2003; 49: 238.
  • 207
    Ganiats TG, Muhlen DG, Kaplan RM, Barrett-Connor E. Gender differences in quality of life in geriatric orthopaedic patients [abstract]. Qual Life Res 1997; 6: 648.
  • 208
    Bombardier C, Raboud J, and the Auranofin Cooperating Group. A comparison of health-related quality-of-life measures for rheumatoid arthritis research. Control Clin Trials 1991; 12: 243S56S.
  • 209
    Moock J, Kohlmann T. Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Qual Life Res 2008; 17: 48595.
  • 210
    Haywood KL, Garratt AM, Fitzpatrick R. Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res 2005; 14: 165168.
  • 211
    Palta M, Chen HY, Kaplan RM, Feeny D, Cherepanov D, Fryback DG. Standard error of measurement of 5 health utility indexes across the range of health for use in estimating reliability and responsiveness. Med Decis Making 2011; 2: 2609.
  • 212
    Frosch DL, Kaplan RM, Ganiats TG, Groessl EJ, Sieber WJ, Weisman MH. Validity of self-administered quality of well-being scale in musculoskeletal disease. Arthritis Rheum 2004; 51: 2833.
  • 213
    AQoL instruments. 2009. URL:
  • 214
    Hawthorne G, Richardson J, Osborne R. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 1999; 8: 20924.
  • 215
    Hawthorne G. Assessing utility where short measures are required: development of the short Assessment of Quality of Life-8 (AQoL-8) instrument. Value Health 2009; 12: 94857.
  • 216
    Busija L, Buchbinder R, Osborne RH. Quantifying the impact of transient joint symptoms, chronic joint symptoms, and arthritis: a population-based approach. Arthritis Rheum 2009; 61: 131221.
  • 217
    Ackerman IN, Graves SE, Wicks IP, Bennell KL, Osborne RH. Severely compromised quality of life in women and those of lower socioeconomic status waiting for joint replacement surgery. Arthritis Rheum 2005; 53: 6538.
  • 218
    Crotty M, Prendergast J, Battersby MW, Rowett D, Graves SE, Leach G, et al. Self-management and peer support among people with arthritis on a hospital joint replacement waiting list: a randomised controlled trial. Osteoarthritis Cartilage 2009; 17: 142833.
  • 219
    Osborne RH, Buchbinder R, Ackerman IN. Can a disease-specific education program augment self-management skills and improve health-related quality of life in people with hip or knee osteoarthritis? BMC Musculoskelet Disord 2006; 7: 90.
  • 220
    Bennell K, Wee E, Coburn S, Green S, Harris A, Staples M, et al. Efficacy of standardised manual therapy and home exercise programme for chronic rotator cuff disease: randomised placebo controlled trial. BMJ 2010; 340: c2756.
  • 221
    Bennell KL, Hinman RS, Metcalf BR, Buchbinder R, McConnell J, McColl G, et al. Efficacy of physiotherapy management of knee joint osteoarthritis: a randomised, double blind, placebo controlled trial. Ann Rheum Dis 2005; 64: 90612.
  • 222
    Galea MP, Levinger P, Lythgo N, Cimoli C, Weller R, Tully E, et al. A targeted home- and center-based exercise program for people after total hip replacement: a randomized clinical trial. Arch Phys Med Rehabil 2008; 89: 14427.
  • 223
    Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 2009; 361: 55768.
  • 224
    Hawthorne G. The effect of different methods of collecting data: mail, telephone and filter data collection issues in utility measurement. Qual Life Res 2003; 12: 10818.
  • 225
    Hawthorne G, Richardson J, Day NA. Using the Assessment of Quality of Life (AQoL) Instrument, version 1.0. Report no. 12. Melbourne: Centre for Health Program Evaluation, University of Melbourne; 2000.
  • 226
    Hawthorne G, Osborne R. Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure. Aust N Z J Public Health 2005; 29: 13642.
  • 227
    Whitfield K, Buchbinder R, Segal L, Osborne RH. Parsimonious and efficient assessment of health-related quality of life in osteoarthritis research: validation of the Assessment of Quality of Life (AQoL) instrument. Health Qual Life Outcomes 2006; 4: 19.
  • 228
    Richardson J, Day NA, Peacock S, Iezzi A. Measurement of the quality of life for economic evaluation and the Assessment of Quality of Life (AQoL) Mark 2 instrument. Aust Health Econ Rev 2004: 1; 6288.
  • 229
    Osborne RH, Hawthorne G, Lew EA, Gray LC. Quality of life assessment in the community-dwelling elderly: validation of the Assessment of Quality of Life (AQoL) instrument and comparison with the SF-36. J Clin Epidemiol 2003; 56: 13847.
  • 230
    Hawthorne G, Richardson J, Day NA. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med 2001; 33: 35870.